TATA HEALTH (01255) receives additional resumption guidance from the Hong Kong Stock Exchange.
TATA Health (01255) announced that on September 12, 2025, the company received a letter from the Hong Kong Stock Exchange...
TATA HEALTH (01255) announced that on September 12, 2025, the company received a letter from the Stock Exchange listing additional guidance for the resumption of trading. The letter specified that the company must conduct an independent internal control review and demonstrate that it has established sufficient internal controls and procedures to meet its responsibilities under the listing rules.
Related Articles
US Stock Market Move | Wolfspeed (WOLF.US) jumped more than 27% after announcing the large-scale commercialization of its 200mm silicon carbide material product portfolio.
US Stock Market Move | ASML Holding NV ADR (ASML.US) rose more than 5%, investing $1.5 billion in the French artificial intelligence startup Mistral AI.
US Stock Market Move | Rare earth concept stocks surged in intraday trading, American Resources (AREC.US) rose more than 16%
US Stock Market Move | Wolfspeed (WOLF.US) jumped more than 27% after announcing the large-scale commercialization of its 200mm silicon carbide material product portfolio.
US Stock Market Move | ASML Holding NV ADR (ASML.US) rose more than 5%, investing $1.5 billion in the French artificial intelligence startup Mistral AI.
US Stock Market Move | Rare earth concept stocks surged in intraday trading, American Resources (AREC.US) rose more than 16%
